Related Experiment Video
Updated: Sep 13, 2025
09:16
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
Published on: October 30, 2016
11.4K
Vaccinia Virus-A Swiss Army Knife Against Cancer
Marcin Stawowczyk1, Yanqi Ye1, Nanhai G Chen1
1ViroMissile, Inc., 505 Coast Blvd South, Suite 208, La Jolla, CA 92037, USA.
Cancers
|July 29, 2025
Summary
Vaccinia virus (VACV) shows promise as an oncolytic immunotherapy. This review explores how VACV effectively targets cancer cells and stimulates a potent anti-cancer immune response, offering a new therapeutic platform.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Advanced cancer necessitates novel treatments beyond conventional therapies.
- Oncolytic viruses offer a promising strategy by selectively killing cancer cells and activating immune responses.
Purpose of the Study:
- To review the potential of vaccinia virus (VACV) as an oncolytic immunotherapy agent.
- To examine VACV's mechanisms for evading immune defenses and its interactions with the immune system.
- To assess current applications and future directions for VACV in cancer treatment.
Main Methods:
- Review of scientific literature on vaccinia virus and oncolytic virotherapy.
- Analysis of VACV's biological properties and immunomodulatory effects.
- Evaluation of clinical and preclinical studies involving VACV for cancer therapy.
Main Results:
- VACV demonstrates selective tumor cell lysis and potent immune stimulation.
- VACV possesses properties that allow it to overcome host antiviral defenses.
- VACV has shown versatility in preclinical models across various cancer types.
Conclusions:
- VACV is a potent and versatile oncolytic virus with significant potential in cancer immunotherapy.
- Harnessing VACV offers a promising avenue for developing durable, T cell-mediated anti-cancer immunity.
- Further research and clinical trials are warranted to optimize VACV-based cancer therapies.
Related Concept Videos
01:30Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
01:03Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
01:51Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:51Vaccinations
45.3K
Overview
45.3K